Literature DB >> 15990999

Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.

Sevil Yasar1, Jozsef Gaal, Zuzana Justinova, Jack Bergman.   

Abstract

RATIONALE: para-Fluoro-L-deprenyl (Fludepryl), a halogenated derivative of L-deprenyl, shares structural similarities with amphetamine and may have potential as a medication for psychostimulant abuse.
OBJECTIVES: p-Fluoro-L-deprenyl was evaluated for psychomotor stimulant, discriminative stimulus, and reinforcing effects in squirrel monkeys.
METHODS: One group of monkeys was trained under a ten-response fixed-ratio (FR10) schedule of stimulus termination to discriminate between methamphetamine (0.32 mg/kg, i.m.) and saline. Other monkeys were trained to self-administer i.v. cocaine under either a simple FR10 schedule or a second-order fixed-interval 5-min schedule with FR10 components.
RESULTS: Full generalization to the methamphetamine-training stimulus was produced by an i.m. dose of 10.0 mg/kg p-fluoro-L-deprenyl. L-Deprenyl and the metabolites of p-fluoro-L-deprenyl, p-fluoro-L-amphetamine, and p-fluoro-L-methylamphetamine were more potent, producing full generalization at doses of 1.0-3.2 mg/kg. Under the FR10 schedule of drug injection, persistent self-administration behavior was maintained by i.v. cocaine injections but not by injections of vehicle or injection doses of p-fluoro-L-deprenyl up to 1.0 mg/kg. However, p-fluoro-L-deprenyl did maintain moderate levels of i.v. self-administration responding under the second-order schedule of drug injection. Peak response rates maintained by 0.1-mg/kg injections of p-fluoro-L-deprenyl were significantly greater than those associated with saline substitution, yet significantly lower than those maintained by cocaine or D-amphetamine.
CONCLUSIONS: p-Fluoro-L-deprenyl has methamphetamine-like discriminative-stimulus properties in squirrel monkeys that appear at higher doses than for its parent compound, L-deprenyl. It also appears to function as a relatively limited reinforcer of intravenous self-administration behavior in monkeys trained to self-administer i.v. cocaine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990999     DOI: 10.1007/s00213-005-0063-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

2.  (-)deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin.

Authors:  J Knoll; V Tóth; M Kummert; J Sugár
Journal:  Mech Ageing Dev       Date:  1992-04       Impact factor: 5.432

3.  (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats.

Authors:  M C Carrillo; S Kanai; M Nokubo; K Kitani
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

Review 4.  [Effect of selegiline against selective neurotoxins].

Authors:  K Magyar
Journal:  Vopr Med Khim       Date:  1997 Nov-Dec

5.  Metabolism of (-)-deprenyl and PF-(-)-deprenyl in brain after central and peripheral administration.

Authors:  A Lajtha; H Sershen; T Cooper; A Hashim; J Gaál
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

6.  Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

Authors:  R E Heikkila; A Hess; R C Duvoisin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

7.  Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition.

Authors:  K S Ansari; P H Yu; T P Kruck; W G Tatton
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

8.  Intravenous self-administration studies with l-deprenyl (selegiline) in monkeys.

Authors:  G D Winger; S Yasar; S S Negus; S R Goldberg
Journal:  Clin Pharmacol Ther       Date:  1994-12       Impact factor: 6.875

9.  Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies.

Authors:  S Yasar; J Bergman
Journal:  Clin Pharmacol Ther       Date:  1994-12       Impact factor: 6.875

10.  A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder.

Authors:  Jay D Amsterdam
Journal:  J Clin Psychiatry       Date:  2003-02       Impact factor: 4.384

View more
  1 in total

1.  A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.

Authors:  Sevil Yasar; József Gaál; Leigh V Panlilio; Zuzana Justinova; Szecsö V Molnár; Godfrey H Redhi; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2005-11-15       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.